Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTDSP1 | Q9GZU7 | 3/20 | 0.34 |
| ▸ | APOBEC3A | P31941 | 2/20 | 0.34 |
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 0.34 |
| ▸ | SIGMAR1 | Q99720 | 8/20 | 0.34 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.31 |
| ▸ | CHRNB4 | P30926 | 4/20 | 0.31 |
| ▸ | CHRNA3 | P32297 | 4/20 | 0.31 |
| ▸ | CHRNA7 | P36544 | 4/20 | 0.31 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.31 |
| ▸ | CHRNA1 | P02708 | 3/20 | 0.31 |
| ▸ | CHRNG | P07510 | 3/20 | 0.31 |
| ▸ | CHRNB1 | P11230 | 3/20 | 0.31 |
| ▸ | CHRND | Q07001 | 3/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | THPO | P40225 | 1/20 | 0.31 |
| ▸ | CHRNE | Q04844 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3213927 | 1.00 | CTDSP1 (0.34) | CTDSP1APOBEC3AAPOBEC3GSIGMAR1CHRNB2 | |
| SCHEMBL1024401 | 0.83 | — | — | |
| SCHEMBL23967319 | 0.79 | CTDSP1 (0.43) | CTDSP1APOBEC3AAPOBEC3GSIGMAR1LMNA | |
| Methyl Alcohol SCHEMBL1155257 | 0.79 | CTDSP1 (0.43) | CTDSP1APOBEC3AAPOBEC3GSIGMAR1CHRNB2 | |
| SCHEMBL9951680 | 0.73 | — | — | |
| Acetic Acid SCHEMBL189531 | 0.72 | CTDSP1 (0.38) | CTDSP1APOBEC3AAPOBEC3GSIGMAR1LMNA | |
| SCHEMBL6581138 | 0.70 | SIGMAR1 (0.41) | CTDSP1APOBEC3AAPOBEC3GSIGMAR1LMNA | |
| SCHEMBL10444957 | 0.70 | CTDSP1 (0.37) | CTDSP1APOBEC3AAPOBEC3GSIGMAR1LMNA | |
| SCHEMBL15476357 | 0.70 | MEN1 (0.30) | LMNA | |
| SCHEMBL16779993 | 0.70 | CTDSP1 (0.36) | CTDSP1APOBEC3AAPOBEC3GSIGMAR1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2104497-B1 | SULFAMIDE DERIVATIVES AS TAFIA INHIBITORS | SANOFI SA (FR) | 2015-02-25 | — | — | EP | claimed |
| US-8389764-B2 | Urea and sulfamide derivatives as inhibitors of TAFIa | SANOFI (FR) | 2013-03-05 | — | — | US | claimed |
| US-20100035930-A1 | UREA AND SULFAMIDE DERIVATIVES AS INHIBITORS OF TAFIa | SANOFI-AVENTIS (FR) | 2010-02-11 | — | — | US | claimed |
| CN-102786837-B | Uv-curing type ink jet compositions and printed article | 精工爱普生株式会社 | 2016-12-07 | — | — | CN | disclosed |
| CN-105965881-A | Three-dimensional modeling apparatus and three-dimensional object manufacturing method | 精工爱普生株式会社 | 2016-09-28 | — | — | CN | disclosed |
| CN-103242702-B | Uv-curing type ink jet compositions and record thing | 精工爱普生株式会社 | 2016-07-13 | — | — | CN | disclosed |
| CN-104924609-A | Apparatus for producing three-dimensional structure, three-dimensional structure and method of producing three-dimensional structure | SEIKO EPSON CORP | 2015-09-23 | — | — | CN | disclosed |
| CN-104908317-A | Three-dimensional structure manufacturing apparatus, manufacturing method of three-dimensional structure, and three-dimensional structure | SEIKO EPSON CORP | 2015-09-16 | — | — | CN | disclosed |
| CN-104908318-A | Manufacturing method of three-dimensional structure, three-dimensional structure manufacturing apparatus, and three-dimensional structure | SEIKO EPSON CORP | 2015-09-16 | — | — | CN | disclosed |
| CN-104859146-A | Three dimensional mold object manufacturing apparatus, method for manufacturing three dimensional mold object, and three dimensional mold object | SEIKO EPSON CORP | 2015-08-26 | — | — | CN | disclosed |
| CN-104842555-A | Apparatus for manufacturing three-dimensional shaped object, method of manufacturing three-dimensional shaped object, and three-dimensional shaped object | SEIKO EPSON CORP | 2015-08-19 | — | — | CN | disclosed |
| EP-2104497-B1 | SULFAMIDE DERIVATIVES AS TAFIA INHIBITORS | SANOFI SA (FR) | 2015-02-25 | — | — | EP | disclosed |
| US-8389764-B2 | Urea and sulfamide derivatives as inhibitors of TAFIa | SANOFI (FR) | 2013-03-05 | — | — | US | disclosed |
| US-20100035930-A1 | UREA AND SULFAMIDE DERIVATIVES AS INHIBITORS OF TAFIa | SANOFI-AVENTIS (FR) | 2010-02-11 | — | — | US | disclosed |
| EP-2104497-A2 | UREA AND SULFAMIDE DERIVATIVES AS TAFIA INHIBITORS | Sanofi-Aventis (FR) | 2009-09-30 | — | — | EP | disclosed |
| WO-2008067909-A2 | UREA AND SULFAMIDE DERIVATIVES AS TAFIA INHIBITORS | SANOFI-AVENTIS (FR) | 2008-06-12 | — | — | WO | disclosed |
| CN-1713787-A | Organic electroluminescent device, method for producing the same, and electronic apparatus | SEIKO EPSON CORP (JP) | 2005-12-28 | — | — | CN | disclosed |
| US-5378691-A | Amino acid derivatives | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1995-01-03 | — | — | US | disclosed |
| EP-0418696-A2 | Derivatives of aminoacids | MERCK PATENT GmbH (DE) | 1991-03-27 | — | — | EP | disclosed |
| CN-1037155-A | Amino acid derivative | MERCK PATENT GMBH (DE) | 1989-11-15 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100035930-A1 | UREA AND SULFAMIDE DERIVATIVES AS INHIBITORS OF TAFIa | TFPI, TFPI2, SERPINE1 | CTDSP1 1124/4885APOBEC3A 1499/4885APOBEC3G 1727/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.